Jonathan S. Berek
Publication Details
-
HER-2/neu targeting for recurrent vulvar Paget's disease A case report and literature review.
Gynecol Oncol. 2008; (3): 568-71
The treatment of Paget's disease of the vulva particularly for recurrences can be challenging. Overexpression of the HER-2/neu protein has been found in about 30% of vulvar Paget's cases therefore presenting a potential therapeutic target.
Help
Trial Administration